Search by Drug Name or NDC

    NDC 55566-1002-01 Ortikos 6 mg/1 Details

    Ortikos 6 mg/1

    Ortikos is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ferring Pharmaceuticals Inc.. The primary component is BUDESONIDE.

    Product Information

    NDC 55566-1002
    Product ID 55566-1002_69c1e200-f5ae-429f-b890-b2418700a7e8
    Associated GPIs 22100012007025
    GCN Sequence Number 079891
    GCN Sequence Number Description budesonide CAPSULE ER 6 MG ORAL
    HIC3 P5A
    HIC3 Description GLUCOCORTICOIDS
    GCN 46496
    HICL Sequence Number 006545
    HICL Sequence Number Description BUDESONIDE
    Brand/Generic Brand
    Proprietary Name Ortikos
    Proprietary Name Suffix n/a
    Non-Proprietary Name Budesonide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 6
    Active Ingredient Units mg/1
    Substance Name BUDESONIDE
    Labeler Name Ferring Pharmaceuticals Inc.
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA211929
    Listing Certified Through 2023-12-31

    Package

    NDC 55566-1002-01 (55566100201)

    NDC Package Code 55566-1002-1
    Billing NDC 55566100201
    Package 30 CAPSULE in 1 BOTTLE (55566-1002-1)
    Marketing Start Date 2020-07-20
    NDC Exclude Flag N
    Pricing Information N/A